This is the second in a 3-part series on ”The Challenges of Patient Recruitment in Oncology Trials”, Senior Patient Recruitment Managers Tricia Buchheit and Lauren Johnson explore the common misconceptions which hinder patient recruitment in oncology trials and how combat and reassure patients with these reservations regarding clinical research.
Explore related content and topics
Webinar
The Challenges of Patient Recruitment in Oncology Trials - Part 3
A Phase I through Phase III oncology trial costs approximately $56.3 million and lasts for eight years. In 2012, it was reported that a typical…
Blog
World Blood Donor Day 2020: Why is Donating Blood Important, Especially During a Pandemic?
To mark World Blood Donor Day, we interviewed two members of our PRA family who have gone above and beyond for Red Cross efforts. We discussed why…
Blog
Ask the Experts: How is the Medical Industry Currently Addressing Sickle Cell Disease?
Sickle Cell Disease (SCD) is a disease with few curative treatments that affects people globally. Both young and older patients who struggle with SCD…